April Wang

Regulatory Affairs Manager, Accestra Consulting

  • AdobeStock_359466877

    China drug master file: registration pathways and requirements


    This is the first article in a six-part series that will focus on the regulations in China’s drug market. There will be different topics each month with the initial focus on the drug master file (DMF) filing process followed by the drug registration process and pharmacovigilance requirements. ...